메뉴 건너뛰기




Volumn 62, Issue 3, 2005, Pages 942-

Treatment of thymoma and prognostic factors: In regard to Zhu et al. (Int J Radiat Oncol Biol Phys 2004;60:1113-1119) [3]

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; IMATINIB; STEM CELL FACTOR;

EID: 20344378192     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.011     Document Type: Letter
Times cited : (1)

References (6)
  • 1
    • 7444233164 scopus 로고    scopus 로고
    • Radiotherapy and prognostic factors for thymoma: A retrospective study of 175 patients
    • G. Zhu, S. He, X. Fu Radiotherapy and prognostic factors for thymoma A retrospective study of 175 patients Int J Radiat Oncol Biol Phys 60 2004 1113 1119
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , pp. 1113-1119
    • Zhu, G.1    He, S.2    Fu, X.3
  • 2
    • 2342510977 scopus 로고    scopus 로고
    • Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis
    • P. Strobel, A. Bauer, B. Puppe Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas a retrospective analysis J Clin Oncol 22 2004 1501 1509
    • (2004) J Clin Oncol , vol.22 , pp. 1501-1509
    • Strobel, P.1    Bauer, A.2    Puppe, B.3
  • 3
    • 11144354401 scopus 로고    scopus 로고
    • WHO histologic classification is a prognostic indicator in thymoma
    • K. Kondo, K. Yoshizawa, M. Tsuyuguchi WHO histologic classification is a prognostic indicator in thymoma Ann Thorac Surg 77 2004 1183 1188
    • (2004) Ann Thorac Surg , vol.77 , pp. 1183-1188
    • Kondo, K.1    Yoshizawa, K.2    Tsuyuguchi, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.